secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2022-07-06T23:59:59+00:00
Accession:  0001104659-22-077715
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health appoints Dr. Anula Jayasuriya to board, forms Business Development Advisory Committee
--------------------------------------------------------------------------------

- Greg Divis resigned from Jaguar Health board effective July 1, 2022, after serving since 2018.
- Dr. Anula Jayasuriya appointed as Class III director effective July 1, 2022; founder of EXXclaim Capital.
- Board formed Business Development Advisory Committee chaired by Rachel Zolot Schwartz, VP at Volastra Therapeutics.
- Dr. Jayasuriya receives $40,000 cash retainer and 128,851 restricted stock units under the 2014 Stock Incentive Plan.
- Committee to identify and assess opportunities for potential alliances, mergers, and acquisitions for crofelemer asset.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000110465922077715/0001104659-22-077715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000110465922077715/tm2220394d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-077715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer